Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Canada
0
Australia
0
South Africa
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Agyrax
2. Antivert
3. Bonamine
4. Bonine
5. Chiclida
6. D Vert
7. D-vert
8. Dihydrochloride, Meclizine
9. Dvert
10. Histametizyn
11. Hydrochloride, Meclizine
12. Meclizine
13. Meclizine Dihydrochloride
14. Meclizine Hydrochloride
15. Meclizine Monohydrochloride
16. Meclozine
17. Monohydrochloride, Meclizine
18. Parachloramine
19. Ru Vert M
20. Ru-vert-m
1. Meclizine Hydrochloride
2. Meclizine Dihydrochloride Monohydrate
3. 31884-77-2
4. Postafen
5. Agyrax
6. Bonamine
7. Hdp7w44cio
8. Meclozine Hydrochloride Monohydrate
9. Ucb-5062
10. 1-[(4-chlorophenyl)-phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine;hydrate;dihydrochloride
11. Nsc-757094
12. Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((3-methylphenyl)methyl)-, Dihydrochloride, Monohydrate
13. Mfcd00941489
14. Meclizine Hcl Hydrate
15. Nsc-28728
16. Unii-hdp7w44cio
17. Antivert (tn)
18. Chembl3989555
19. Chebi:31805
20. Dtxsid30953792
21. Meclizine Hydrochloride (jan/usp)
22. Meclizine Hydrochloride [usp:jan]
23. Bcp13363
24. Meclizine Hydrochloride [jan]
25. Meclizine Hydrochloride [vandf]
26. Nsc 757094
27. 1-(p-chloro-alpha-phenylbenzyl)-4-(m-methylbenzyl)piperazine Dihydrochloride Monohydrate
28. Meclizine Hydrochloride [usp-rs]
29. As-13740
30. Meclizine Hydrochloride [orange Book]
31. D01317
32. Meclizine Hydrochloride [usp Monograph]
33. A821043
34. Meclizine Dihydrochloride Monohydrate [mi]
35. (+/-)-meclizine Dihydrochloride Monohydrate
36. Meclozine Hydrochloride Monohydrate [who-dd]
37. Meclizine Dihydrochloride Monohydrate, (+/-)-
38. Q27279880
39. 1-((4-chlorophenyl)(phenyl)methyl)-4-(3-methylbenzyl)piperazine Dihydrochloride Hydrate
40. 1-((4-chlorophenyl)(phenyl)methyl)-4-(3-methylbenzyl)piperazinedihydrochloridehydrate
41. 1-(p-chloro-alpha-phenylbenzyl)-4-(m-methylbenzyl) Piperazine Dihydrochloride Monohydrate
42. 1-(p-chloro-.alpha.-phenylbenzyl)-4-(m-methylbenzyl)piperazine Dihydrochloride Monohydrate
43. 1-[(4-chlorophenyl)(phenyl)methyl]-4-[(3-methylphenyl)methyl]piperazine--hydrogen Chloride--water (1/2/1)
44. 1-[(4-chlorophenyl)-phenyl-methyl]-4-(m-tolylmethyl)piperazine Hydrate Dihydrochloride;meclizine Dihydrochloride Monohydrate
45. 1-[(4-chlorophenyl)phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine Dihydrochloride Hydrate
Molecular Weight | 481.9 g/mol |
---|---|
Molecular Formula | C25H31Cl3N2O |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 5 |
Exact Mass | 480.150197 g/mol |
Monoisotopic Mass | 480.150197 g/mol |
Topological Polar Surface Area | 7.5 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 448 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
1 of 1 | |
---|---|
Drug Name | MECLIZINE HYDROCHLORIDE |
Active Ingredient | MECLIZINE HYDROCHLORIDE |
Company | AMNEAL PHARMS (Application Number: A201451); EPIC PHARMA LLC (Application Number: A200294); JUBILANT CADISTA (Application Number: A040659); MYLAN PHARMS INC (Application Number: A202640); PAR PHARM (Application Number: A087127); PAR PHARM (Application Number: A087128); SANDOZ (Application Number: A084092); SANDOZ (Application Number: A084843) |
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
Cholinergic Antagonists
Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists. (See all compounds classified as Cholinergic Antagonists.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Meclizine hydrochloride anhydrous manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Meclizine hydrochloride anhydrous, including repackagers and relabelers. The FDA regulates Meclizine hydrochloride anhydrous manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Meclizine hydrochloride anhydrous API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Meclizine hydrochloride anhydrous manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Meclizine hydrochloride anhydrous supplier is an individual or a company that provides Meclizine hydrochloride anhydrous active pharmaceutical ingredient (API) or Meclizine hydrochloride anhydrous finished formulations upon request. The Meclizine hydrochloride anhydrous suppliers may include Meclizine hydrochloride anhydrous API manufacturers, exporters, distributors and traders.
click here to find a list of Meclizine hydrochloride anhydrous suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Meclizine hydrochloride anhydrous DMF (Drug Master File) is a document detailing the whole manufacturing process of Meclizine hydrochloride anhydrous active pharmaceutical ingredient (API) in detail. Different forms of Meclizine hydrochloride anhydrous DMFs exist exist since differing nations have different regulations, such as Meclizine hydrochloride anhydrous USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Meclizine hydrochloride anhydrous DMF submitted to regulatory agencies in the US is known as a USDMF. Meclizine hydrochloride anhydrous USDMF includes data on Meclizine hydrochloride anhydrous's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Meclizine hydrochloride anhydrous USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Meclizine hydrochloride anhydrous suppliers with USDMF on PharmaCompass.
A Meclizine hydrochloride anhydrous CEP of the European Pharmacopoeia monograph is often referred to as a Meclizine hydrochloride anhydrous Certificate of Suitability (COS). The purpose of a Meclizine hydrochloride anhydrous CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Meclizine hydrochloride anhydrous EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Meclizine hydrochloride anhydrous to their clients by showing that a Meclizine hydrochloride anhydrous CEP has been issued for it. The manufacturer submits a Meclizine hydrochloride anhydrous CEP (COS) as part of the market authorization procedure, and it takes on the role of a Meclizine hydrochloride anhydrous CEP holder for the record. Additionally, the data presented in the Meclizine hydrochloride anhydrous CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Meclizine hydrochloride anhydrous DMF.
A Meclizine hydrochloride anhydrous CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Meclizine hydrochloride anhydrous CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Meclizine hydrochloride anhydrous suppliers with CEP (COS) on PharmaCompass.
A Meclizine hydrochloride anhydrous written confirmation (Meclizine hydrochloride anhydrous WC) is an official document issued by a regulatory agency to a Meclizine hydrochloride anhydrous manufacturer, verifying that the manufacturing facility of a Meclizine hydrochloride anhydrous active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Meclizine hydrochloride anhydrous APIs or Meclizine hydrochloride anhydrous finished pharmaceutical products to another nation, regulatory agencies frequently require a Meclizine hydrochloride anhydrous WC (written confirmation) as part of the regulatory process.
click here to find a list of Meclizine hydrochloride anhydrous suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Meclizine hydrochloride anhydrous as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Meclizine hydrochloride anhydrous API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Meclizine hydrochloride anhydrous as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Meclizine hydrochloride anhydrous and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Meclizine hydrochloride anhydrous NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Meclizine hydrochloride anhydrous suppliers with NDC on PharmaCompass.
Meclizine hydrochloride anhydrous Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Meclizine hydrochloride anhydrous GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Meclizine hydrochloride anhydrous GMP manufacturer or Meclizine hydrochloride anhydrous GMP API supplier for your needs.
A Meclizine hydrochloride anhydrous CoA (Certificate of Analysis) is a formal document that attests to Meclizine hydrochloride anhydrous's compliance with Meclizine hydrochloride anhydrous specifications and serves as a tool for batch-level quality control.
Meclizine hydrochloride anhydrous CoA mostly includes findings from lab analyses of a specific batch. For each Meclizine hydrochloride anhydrous CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Meclizine hydrochloride anhydrous may be tested according to a variety of international standards, such as European Pharmacopoeia (Meclizine hydrochloride anhydrous EP), Meclizine hydrochloride anhydrous JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Meclizine hydrochloride anhydrous USP).
LOOKING FOR A SUPPLIER?